Loading...
Loading...
India's acetaminophen imports from UNITED STATES total $34.9K across 73 shipments from 15 foreign suppliers. AKRON PHARMA leads with $24.8K in import value; the top 5 suppliers together control 91.1% of this origin. Leading Indian buyers include KJD PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for acetaminophen — a diversified sourcing base with multiple active suppliers from UNITED STATES.

AKRON PHARMA is the leading Acetaminophen supplier from UNITED STATES to India, with import value of $24.8K across 12 shipments. The top 5 suppliers — AKRON PHARMA, SAVI CLINICALS FZ LLC, Bilcare GCS INC., PERRIGO PLANT 4, AMSTERDAM PHARMA (APTEKA RX INC) — collectively account for 91.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AKRON PHARMA | $24.8K | 12 | 71.0% |
| 2 | SAVI CLINICALS FZ LLC | $3.3K | 2 | 9.4% |
| 3 | Bilcare GCS INC. | $2.0K | 1 | 5.8% |
| 4 | PERRIGO PLANT 4 | $941 | 5 | 2.7% |
| 5 | AMSTERDAM PHARMA (APTEKA RX INC) | $773 | 3 | 2.2% |
| 6 | AGRACE PHARMA | $673 | 2 | 1.9% |
| 7 | GRANULES PHARMACEUTICALS INC | $487 | 1 | 1.4% |
| 8 | JUPITER RESEARCH SERVICES LLC | $368 | 1 | 1.1% |
| 9 | AMSTERDAM PHARMA (APTEKA RX INC.) | $337 | 1 | 1.0% |
| 10 | INWOOD PHARMA INC. | $268 | 1 | 0.8% |
| 11 | GSK CONSUMER HEALTHCARE (HALEON) | $194 | 2 | 0.6% |
| 12 | AGRACE PHARMA. | $170 | 3 | 0.5% |
| 13 | GRANULES USA INC | $155 | 17 | 0.4% |
| 14 | M/S. ESPEE BIOPHARMA & FINCHEM LLC | $114 | 1 | 0.3% |
| 15 | GRANULES PHARMACEUTICALS | $101 | 1 | 0.3% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | KJD PHARMA PRIVATE LIMITED | $24.8K | 12 | 71.0% |
| 2 | BIOLOGICAL E. LIMITED | $3.3K | 2 | 9.4% |
| 3 | INDOCO REMEDIES LIMITED | $2.0K | 1 | 5.8% |
| 4 | VIMTA LABS LIMITED | $941 | 5 | 2.7% |
| 5 | INVENTIA HEALTHCARE LIMITED | $773 | 3 | 2.2% |
| 6 | GRANULES INDIA LIMITED | $756 | 20 | 2.2% |
| 7 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $673 | 2 | 1.9% |
| 8 | TENSHI KAIZEN PRIVATE LIMITED | $368 | 1 | 1.1% |
| 9 | MACLEODS PHARMACEUTICALS LTD | $337 | 1 | 1.0% |
| 10 | GLENMARK PHARMACEUTICALS LIMITED | $268 | 1 | 0.8% |
| 11 | SARVOTHAM CARE LIMITED | $194 | 2 | 0.6% |
| 12 | DR.REDDY'S LABORATORIES LTD | $170 | 3 | 0.5% |
| 13 | RUBICON RESEARCH PRIVATE LIMITED | $114 | 1 | 0.3% |
| 14 | ECRON ACUNOVA LIMITED | $54 | 2 | 0.2% |
| 15 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $54 | 2 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Acetaminophen suppliers from UNITED STATES to India include AKRON PHARMA, SAVI CLINICALS FZ LLC, Bilcare GCS INC.. The leading supplier is AKRON PHARMA with import value of $24.8K USD across 12 shipments. India imported Acetaminophen worth $34.9K USD from UNITED STATES in total across 73 shipments.
India imported Acetaminophen worth $34.9K USD from UNITED STATES across 73 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Acetaminophen sourced from UNITED STATES include KJD PHARMA PRIVATE LIMITED, BIOLOGICAL E. LIMITED, INDOCO REMEDIES LIMITED. The largest buyer is KJD PHARMA PRIVATE LIMITED with $24.8K in imports across 12 shipments.
The total value of Acetaminophen imports from UNITED STATES to India is $34.9K USD, across 73 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
73 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists